4 results match your criteria: "Clinical Capability[Affiliation]"
The State of STEMI Care Across NSW: A Comparison of Rural, Regional, and Metropolitan Centres.
Heart Lung Circ
December 2024
Cardiology Department, Orange Health Service, Western NSW Local Health District, Orange, NSW, Australia.
Background: At a global level, regional variation in the management of ST-elevation myocardial infarction (STEMI) is influenced by patient demographics and geography. Rural patients with STEMI are disadvantaged in reaching timely care owing to distance and limited ambulance and healthcare resources. Optimising models of STEMI care is key to overcoming the excess rural vs metropolitan cardiovascular morbidity and mortality.
View Article and Find Full Text PDFEvaluating the effectiveness of the maximum permitted dose of midazolam in seizure termination: Insights from New South Wales, Australia.
Emerg Med Australas
October 2024
Ambulance Service of New South Wales, Clinical Capability, Safety and Quality, Sydney, New South Wales, Australia.
Objective: Out-of-hospital seizures demand rapid management. Midazolam plays a key role in stopping seizures. At times the first dose of midazolam proves insufficient, necessitating additional doses.
View Article and Find Full Text PDFPre-positioned Outbreak Research: The Joint Medical Emerging Diseases Intervention Clinical Capability Experience in Uganda.
Health Secur
October 2020
Karen A. Martins, PhD, is Research Health Science Program Manager, Medical Division; Chi Ritchie, MT, M(ASCP), is a Microbiologist; and Sina Bavari, PhD, is Science Director; all at the US Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD. Rodgers R. Ayebare, MB ChB, CIC, is Site Coordinator; and Peter Waitt, MD, is Clinical Lead, Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC), Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda. Nahid Bhadelia, MD, MA, is Associate Professor and Medical Director, Special Pathogens Unit, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA. Francis Kiweewa, MD, is Head of Research and Scientific Affairs, Makerere University Walter Reed Project, and Strengthening Institutional Capacity for Research Administration (SICRA), Kampala, Uganda. Derrick Mimbe, MSC, and Stephen Okello, MD, are Program Managers, JMEDICC; Prossy Naluyima, PhD, is Laboratory Director; and Hannah Kibuuka, MD, is Executive Director, all in the Makerere University Walter Reed Project, Kampala, Uganda. David M. Brett-Major, MD, MPH, is a Professor, College of Public Health, and James V. Lawler, MD, MPH, is Executive Director, International Programs and Innovation, Global Center for Health Security and Division of Infectious Diseases; both at the University of Nebraska Medical Center, Omaha, NE. Monica Millard, MPH, is Country Program Director, US Army Medical Research Directorate-Africa/Uganda (MRD-A/U), Walter Reed Army Institute of Research (WRAIR), Kampala, Uganda. Richard Walwema is a Laboratorian, and Mohammed Lamorde, PhD, is Head of Global Health Security, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda. Anthony P. Cardile, DO, is at the Richard Barquist US Army Health Clinic, Ft. Detrick, MD. Antonia Kwiecien and Helen Badu are International Program Managers-Uganda, and Danielle V. Clark, PhD, is Director; all at Austere environments Consortium for Enhanced Sepsis Outcomes (ACESO), Henry M. Jackson Foundation, Bethesda, MD. Benjamin J. Espinosa, PhD, is Deputy Director, Biological Defense Research Directorate, Naval Medical Research Center, Frederick, MD. Charmagne Beckett, MD MPH, is with the Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, MD. Saima Zaman, MPH, is International Project Manager, Biological Threat Reduction Program, Defense Threat Reduction Agency, Fort Belvoir, VA. George Christopher, MD, is Joint Project Manager, Chemical, Biological, Radiological, and Nuclear Medical, Joint Program Executive Office for CBRN Defense, US Department of Defense, Fort Detrick, MD.
The West Africa Ebola virus disease outbreak of 2014-2016 demonstrated that responses to viral hemorrhagic fever epidemics must go beyond emergency stopgap measures and should incorporate high-quality medical care and clinical research. Optimal patient management is essential to improving outcomes, and it must be implemented regardless of geographical location or patient socioeconomic status. Coupling clinical research with improved care has a significant added benefit: Improved data quality and management can guide the development of more effective supportive care algorithms and can support regulatory approvals of investigational medical countermeasures (MCMs), which can alter the cycle of emergency response to reemerging pathogens.
View Article and Find Full Text PDFTrauma care at a multinational United Kingdom-led Role 3 combat hospital: resuscitation outcomes from a multidisciplinary approach.
Mil Med
November 2014
The Eisenhower School, National Defense University, 117 South Aberdeen Street, Arlington, VA 22204.
Unlabelled: Recent conflicts have led significant advancements in casualty care. Facilities serving combat wounded operate in challenging environments. Our purpose is to describe the multidisciplinary resuscitation algorithm utilized at a United Kingdom-led, Role 3 multinational treatment facility in Afghanistan focusing on injury severity and in-hospital mortality.
View Article and Find Full Text PDF